Zoetis Announces Expanded Commitments to Protect the Planet
January 06 2022 - 8:00AM
Business Wire
- Commits to carbon neutrality in company operations by 2030
- Accelerates commitment to 100% renewable energy
Zoetis Inc. (NYSE:ZTS), the world’s leading animal health
company, has refreshed its Driven to Care sustainability
aspirations for mitigating the company’s climate impact and
environmental effects on the planet. Focusing first on its own
operations, Zoetis is striving to achieve carbon neutrality by
2030. This includes accelerating the company’s commitment to
Renewable Energy 100 (RE100) to use 100% renewable energy in its
operations. The company’s updated commitments are underscored by
investments in technology and a strong governance structure.
“Our vision is to be the most sustainable animal health company
in the world, and we are proud to be the first stand-alone animal
health company to commit to carbon neutrality by 2030,” said
Jeannette Ferran Astorga, Executive Vice President, Corporate
Affairs, Communications and Sustainability at Zoetis. “Launching
our expanded climate strategy reflects an evolution of our journey.
As we live our purpose to nurture the world and humankind by
advancing care for animals, we are focused on stewarding resources
responsibly and minimizing our own operations’ impact on the
environment to help protect our planet.”
Advancing the company’s accelerated goal to use 100% renewable
energy in its operations by 2030, Zoetis has initiated a formal
approach to procuring renewable energy through power purchase
agreements, including a new 15-year virtual power purchase
agreement with Vesper Energy, which will generate more than 40
megawatts of renewable energy to power approximately 33% of Zoetis’
North American operations’ projected energy needs. These efforts
are focused in North America because it represents approximately
75% of the company’s global electricity consumption.
As another step in its sustainability journey, the company’s
diagnostics site in San Diego is operating on 100% renewable
electricity, which means 9 of the company’s 28 manufacturing sites,
along with the company’s three PHARMAQ sites in Norway, are
operating on 100% renewable energy now. Additionally, Zoetis’
offices in Zaventem, Belgium, and Dublin, Ireland – the company’s
largest offices outside of the United States – are now being
powered by 100% renewable electricity.
Key energy efficiency projects have included ongoing
optimization of heating, ventilation, and air conditioning (HVAC)
equipment as well as a continuous program to improve lighting
efficiency with LED bulbs. Zoetis also continues to invest in
updated technology to be more energy efficient at its manufacturing
sites; one recent example is retrofitting a spray dryer at the
company’s Chicago Heights, Illinois, manufacturing site, resulting
in a 10% reduction in energy consumption. The company also has
progressed energy efficiency at its research and development
locations. A program at its global research and development
headquarters in Kalamazoo, Michigan, delivered 8,000 gigajoules of
savings in 2021, and an ongoing project to deploy photovoltaic
solar panels at its Thane site in India will deliver up to 5% of
site electricity requirements.
To further manage and achieve its carbon neutrality targets,
Zoetis is focused on procurement activities to electrify more of
its fleet of vehicles, improve on its energy efficiency annually,
offset the final share of Scope 1 and 2 emissions, and create
greater transparency into Scope 3 emissions.
In recognition of its progress on sustainability, Zoetis was
named one of Newsweek’s Most Responsible Companies for 2022 and was
included in Investor’s Business Daily’s 100 Best ESG Companies. In
2021, the company announced its Driven to Care long-term
sustainability strategy and goals followed by its first
Sustainability Report. Zoetis will continue to share updates on its
sustainability activities, including progress against its Driven to
Care goals, and report annually.
About Zoetis
As the world’s leading animal health company, Zoetis is driven
by a singular purpose: to nurture our world and humankind by
advancing care for animals. After 70 years innovating ways to
predict, prevent, detect, and treat animal illness, Zoetis
continues to stand by those raising and caring for animals
worldwide -- from livestock farmers to veterinarians and pet
owners. The company’s leading portfolio and pipeline of medicines,
vaccines, diagnostics and technologies make a difference in over
100 countries. A Fortune 500 company, Zoetis generated revenue of
$6.7 billion in 2020 with approximately 11,300 employees. For more
information, visit www.zoetis.com.
DISCLOSURE NOTICES Forward-Looking
Statements: This press release contains forward-looking statements,
which reflect the current views of Zoetis with respect to: ESG
commitments, goals and aspirations, the plans and future work of
the Zoetis Foundation, and other future events. These statements
are not guarantees of future performance or actions.
Forward-looking statements are subject to risks and uncertainties.
If one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise.
A further list and description of risks, uncertainties and other
matters can be found in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2020, including in the sections
thereof captioned “Forward-Looking Statements and Factors That May
Affect Future Results” and “Item 1A. Risk Factors,” in our
Quarterly Reports on Form 10-Q and in our Current Reports on Form
8-K. These filings and subsequent filings are available online at
www.sec.gov, www.zoetis.com, or on request from Zoetis.
All trademarks are the property of Zoetis Services LLC or a
related company or a licensor unless otherwise noted.
© 2022 Zoetis Services LLC. All rights reserved.
ZTS-COR ZTS-IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220105006037/en/
Media: Christina Lood
1-973-822-7249 (o) christina.lood@zoetis.com
Bill Price 1-973-443-2742 (o) william.price@zoetis.com
Investor: Steve Frank
1-973-822-7141 (o) steve.frank@zoetis.com
Keith Gaub 1-973-822-7154 (o) keith.gaub@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024